chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, SARS-CoV-2 test
Clinical narrative: My arm is sore; my arm was sore, it is still sore; I wasn't feeling right, my breath was not right/shortness of breath; Chills; I wasn't feeling right, my breath was not right; temperature was 101; This is a spontaneous report from a contactable Consumer (patient). A 59-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6208) via an unspecified route of administration in left arm on 11Mar2021 as single dose for covid-19 immunization. The medical history included acid reflux. The concomitant medication included Pantoprazole taken for acid reflux (40 mg, Once every other day for acid reflux) and Patient had been taking it from past 3 years. In Mar2021, the patient experienced that his arm was sore and it was still sore, patient wasn't feeling right, his breath was not right, shortness of breath, don't feel good, went to the bathroom a lot and chills. Patient further explained his arm was just a little sore other stuff went away. It was also reported, that was all until last Monday, after Monday I still have sore arm, my arm is still sore but I don't have shortness of breath anymore. patient is supposed to go back on the 2nd of Apr for his shot. Patient reported that he took some Tylenol and NyQuil for the chills and all. The patient underwent lab test of blood test and diabetes check-up and temperature was 101, SWAB test and it was positive 22Feb2021. The outcome of the event arm was sore was not recovered, wasn't feeling right, breath was not right, chills was recovered.   No follow-up attempt are needed. No further information expected.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on neck, face, forearm; Rash on neck, face, forearm; Rash on neck, face, forearm; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 12Mar2021 at 09:15 (at the age of 25-year-old), as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. On 16Mar2021, the patient experienced rash on neck, face and forearm. The patient did not receive any treatment for the reported event. The clinical outcome of rash on neck, face, forearm was not resolved at the time of reporting.   Amendment: This follow-up report is being submitted to amend previously reported information: 1. recoded event term for "Rash on neck, face, forearm" 2. Updated final sentence as No follow-up attempts are possible; information about lot/batch number cannot be obtained  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pain in extremity
Clinical narrative: body aches; Fatigue; severe left arm pain; This is a spontaneous report from a contactable other health care professional. A 23-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation solution for injection; Batch/Lot Number and Expiration date was unknown) via an intramuscular route of administration in Left Arm on 17Mar2021 at 14:00 (at the age of 23-year-old) as dose 1, single for COVID-19 immunization. The patient medical history included COVID-19 (Prior to vaccination, was the patient diagnosed with COVID-19: Yes), food allergy (Allergies to medications, food, or other products:FOODS- SPICES), gluten sensitivity (NON-CELIAC GLUTEN INTOLERANCE) from an unknown date and unknown if ongoing. The patient concomitant medication included ethinylestradiol;ferrous fumarate;norethisterone acetate taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested positive for COVID-19. The facility where the most recent COVID-19 vaccine was administered was at a military base. On 17Mar2021, the patient had experienced severe left arm pain and fatigue at 16:00. On 18Mar2021, the patient experienced body aches. It was reported that the patient had severe left arm pain on the day and day after the vaccination, experienced fatigue 2 hours after injection and body aches only occurred day after, the patient felt better after taking NSAIDS. The clinical outcome of the events was recovered on an unspecified date.  No follow-up attempts are possible; information about lot number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: Updated the relevant history for COVID-19, FOODS- SPICES allergy, NON-CELIAC GLUTEN INTOLERANCE; added information in Best Doctor / Health Care Professional Information; Treatment Received ticked No for event severe left arm pain and Fatigue; Recoded concomitant drug LO LO ESTRIN; Ticked Vaccine Administered at Military Facility as Yes.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Sore swollen lymph nodes; This is a spontaneous report received from a non-contactable consumer, the patient. A 34-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 20Mar2021 (at the age of 34-year-old) as a dose 1, single and the patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration in arm left as a dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced sore swollen lymph nodes on 21Mar2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of event lymphadenopathy was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: arm left was removed from anatomical location since no information was provided for dose 1, AE recoded as swollen lymph nodes and final sentence updated.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Nasal congestion
Clinical narrative: Cough; Nasal congestion; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via unspecified route administration in the left arm on 16Mar2021 at 14:15 (at the age of 19-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested positive for COVID-19. On an unspecified date in Mar2021, the patient developed cough and nasal congestion. The clinical outcome of cough and nasal congestion was unknown.   No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: Update the patient's first name, capitalized the first letter
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Outbreak of shingles on mid-upper back left side. Happened within a week of getting vaccinated. First outbreak of shingles ever, had chicken pox as a kid.; This is a spontaneous report from a contactable consumer (Patient) or other non-health care professional. A 35-years-old male patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 25Feb2021 at 16:00 (Age at vaccination: 35 years) as dose 2, single for covid-19 immunization. Medical history included chicken pox as a kid. Previously the patient took first dose of BNT162B2 via an unspecified route of administration, administered in Arm Left on 04Feb2021 at 04:00 PM as single dose for covid-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient did not had allergies to medications, food, or other products. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) and naltrexone. The patient experienced outbreak of shingles on mid-upper back left side, happened within a week of getting vaccinated, first outbreak of shingles on 01Mar2021. Therapeutic measures were taken as a result of event which included antiviral tablets and topical cream. The adverse event result in Emergency room/department or urgent care. The outcome of the event was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Nausea, Pain, Pyrexia
Clinical narrative: This is a spontaneous report received from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) as a single dose via an unspecified route of administration in left arm on 22Mar2021, at 14:45 PM (at the age of 52 years) for COVID-19 immunisation. The patient had no known medical history.  It was reported that there are no allergies to medications, food or other products. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not diagnosed with COVID-19 prior to vaccination. Concomitant medication was not reported. The patient had not tested positive for COVID-19 since having the vaccine. On 23Mar2021 at 10:00, the patient reported that she had fever, nausea without vomiting, headache and body ache. The patient did not received any treatment for the reported events. The clinical outcome of the event fever, nausea without vomiting, headache and body ache was not resolved at the time of this report. No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Chills, Fatigue, Headache
Clinical narrative: fever 99-100.3; headache; sinus pressure andcongestion; sinus pressure andcongestion; low back pain; fatigue; body chills; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 14:00 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had allergies to sulpha, amoxicillin, tetracyclines, Levaquin and Augmentin. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine, liothyronine (THYROID NP) 1.25 grain and new mood supplement (1/night). Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9267) via an unspecified route of administration in the left arm on 18Feb2021 at 16:30 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. On 22Mar2021 at 14:00, the patient experienced sudden onset of fever 99-100.3, headache, sinus pressure and congestion, low back pain, fatigue and body chills. On 22Mar2021 at 14:00, the patient underwent lab test which include body temperature which measured 99-100.3. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was taken for the events. The clinical outcome of the events sudden onset of fever 99-100.3, headache, sinus pressure and congestion, low back pain, fatigue and body chills were unknown at the time of this report.                  No follow-up attempts possible. No further information expected
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Paranasal sinus discomfort, Pyrexia, Sinus congestion
Clinical narrative: fever 99-100.3; headache; sinus pressure andcongestion; sinus pressure andcongestion; low back pain; fatigue; body chills; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 14:00 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had allergies to sulpha, amoxicillin, tetracyclines, Levaquin and Augmentin. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine, liothyronine (THYROID NP) 1.25 grain and new mood supplement (1/night). Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9267) via an unspecified route of administration in the left arm on 18Feb2021 at 16:30 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. On 22Mar2021 at 14:00, the patient experienced sudden onset of fever 99-100.3, headache, sinus pressure and congestion, low back pain, fatigue and body chills. On 22Mar2021 at 14:00, the patient underwent lab test which include body temperature which measured 99-100.3. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was taken for the events. The clinical outcome of the events sudden onset of fever 99-100.3, headache, sinus pressure and congestion, low back pain, fatigue and body chills were unknown at the time of this report.                  No follow-up attempts possible. No further information expected
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Myalgia, Vaccination site pain
Clinical narrative: Pain around injection site; stiff shoulder; left muscle sore; This is a spontaneous report from a contactable consumer (patient himself). A 64-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: en6198), via an unspecified route of administration in the left arm on 23Mar2021 at 14:00 (at the age of 64-year-old) as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. The patient previously received bnt162b2 (lot number: er2613) on 22Mar2021 administration on left arm as dose 1, single for COVID-19 immunisation. The patient received other medications within 2 weeks of vaccination. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021, 08:00 AM, the patient experienced pain around injection site, stiff shoulder, left muscle sore. The patient did not receive any treatment for the events. The outcome of the events was reported as recovering.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue, Throat irritation
Clinical narrative: Itchy throat; Swollen tongue; This is a spontaneous report from a non-contactable consumer or other non hcp. A 29-years-old female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as (at the age of 29 years) DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation the patient was not diagnosed and didn't get tested with COVID-19 prior to vaccination. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced itchy throat, swollen tongue patient did not had emergency room visit or physician office for these events. The outcome of the events throat irritation, swollen tongue was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information Final sentence "Information about lot/batch number cannot be obtained. No further information is expected." updated as "No follow-up attempts are possible; information about lot/batch number cannot be obtained." Initial information need review for adverse events Itchy throat, swollen tongue. Outcome of the events was reported as unknown, patient did not received any treatment for the adverse events.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vertigo
Clinical narrative: nausea; severe vertigo lasted 4-5 days; This is a spontaneous report from a non-contactable consumer, the patient. A 73-year-old non-pregnant female patient received first dose of BNT162b2(PFIZER- BIONTECH COVID-19 mRNA Vaccine, Lot number: EL9267) via an unspecified route of administration in the left arm on 24Feb2021 at 16:30 (at the age of 73-years-old) and the second dose of BNT162b2(PFIZER- BIONTECH COVID-19 mRNA Vaccine, Lot number: EN6208) via an unspecified route of administration in the left arm on 17Mar2021 at 15:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included eczema and osteopenia. The patient had known allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 25Feb2021, the patient experienced nausea and severe vertigo that lasted for 4-5 days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not received treatment for the reported events. The clinical outcome of the events nausea and severe vertigo was recovered on an unknown date, at the time of this report.    No follow up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Pyrexia
Clinical narrative: High fever; Chills; Joint pain; Incredible headache; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP-7534), via an unspecified route of administration in the left arm on 18Mar2021 at 13:15 (at the age of 59-years-old), as a single dose for COVID-19 immunisation. Medical history included seizure, hay fever. The patient was allergic to melons, avocado and sometimes bananas. Concomitant medications included phenobarbital (MANUFACTURER UNKNOWN) for unspecified indication from unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via an unspecified route of administration in the left arm on 25Feb2021 at 12:45, (at the age of 59-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 19Mar2021 at 05:00, the patient experienced high fever, chills, joint pain and incredible headache which continued through 21Mar2021 (Sunday). The patient was able to eat and drink, but fever and joint pain and headache went on and on. The patient had been struggling to get back into the routine. The patient did not receive any treatment for events. The clinical outcome of the events high fever, chills, headache and joint pain was recovered with sequelae.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Blood test, Cardiac disorder, Electrocardiogram
Clinical narrative: Palpitations; I have something wrong with my atrial; Blood pressure also has increased significantly; This is a spontaneous report from a contactable consumer (patient herself). A 51-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, batch/lot number and expiration date were unknown), via an unspecified route of administration in left arm on 09Mar2021 at 10:15 (at the age of 51-year-old) as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received cefadroxil (CEPHADROXIL) and experienced drug allergy, varenicline tartrate (CHANTIX) and experienced drug allergy. Known allergies: Supposedly CEPHADROXIL and bad reaction to CHANTIX. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, it was unknown whether the patient diagnosed with COVID-19 or not. Since the vaccination, the patient has not been tested for COVID-19. On 09Mar2021 at 21:00, the patient experienced palpitations. Went to doctor who ran an EKG and now she have something wrong with her atrial. Patient blood pressure also has increased significantly. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The events were considered as non-serious by the consumer. The patient underwent lab tests and procedures which included EKG (electrocardiogram): Now she have something wrong with her atrial on an unspecified date, blood works: Unknown results on an unspecified date, blood pressure: Increased on 09Mar2021 at 21:00. The patient was treated with BP (blood pressure) medications at the moment for adverse events and blood work done. The outcome of the events was not resolved.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Palpitations; I have something wrong with my atrial; Blood pressure also has increased significantly; This is a spontaneous report from a contactable consumer (patient herself). A 51-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, batch/lot number and expiration date were unknown), via an unspecified route of administration in left arm on 09Mar2021 at 10:15 (at the age of 51-year-old) as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received cefadroxil (CEPHADROXIL) and experienced drug allergy, varenicline tartrate (CHANTIX) and experienced drug allergy. Known allergies: Supposedly CEPHADROXIL and bad reaction to CHANTIX. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, it was unknown whether the patient diagnosed with COVID-19 or not. Since the vaccination, the patient has not been tested for COVID-19. On 09Mar2021 at 21:00, the patient experienced palpitations. Went to doctor who ran an EKG and now she have something wrong with her atrial. Patient blood pressure also has increased significantly. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The events were considered as non-serious by the consumer. The patient underwent lab tests and procedures which included EKG (electrocardiogram): Now she have something wrong with her atrial on an unspecified date, blood works: Unknown results on an unspecified date, blood pressure: Increased on 09Mar2021 at 21:00. The patient was treated with BP (blood pressure) medications at the moment for adverse events and blood work done. The outcome of the events was not resolved.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood pressure increased, Blood pressure measurement, Chills, Dizziness
Clinical narrative: Throat tightness; BP 159/84 / BP 162/102; Lightheadedness; Generalized chills / mild rigors; Warmth to body; Palpitations; Pulse 107-121; This is a spontaneous report received from a contactable pharmacist. A 33-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: E19266), via an unspecified route of administration in left arm on 20Feb2021 at 15:30 (age at the time of vaccination was 33-year-old) as a single dose for COVID-19 immunization. The patient did not receive any other vaccines with 4 weeks prior to the COVID vaccine. The patient's medical history was not reported. The patient's concomitant medication included Motrin 600 mg prior to arrival for headache, start and stop date were not reported. It was unknown whether the patient was diagnosed with COVID-19 prior to the vaccination or test for COVID-19 post vaccination.Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9261), via an unspecified route of administration in left arm on 03Feb2021 (age at the time of vaccination was 33-year-old) as a single dose for COVID-19 immunization. On 22Feb2021 immediately after receiving vaccination, the patient complained of complained of light-headedness, generalized chills, warmth to body, and palpitations at 10:04. The patient did not eat breakfast. The patient had similar reaction after receiving the first dose, which self-resolved after a minute.  At 10:05, BP was at 159/84 and pulse 88 (unspecified units); the patient was given water. At 10:25, the patient had verbalized feeling better and was able to ambulate without dizziness. At 10:33, the patient developed chills, mild rigors, and throat tightness. The patient's blood sugar was at 85, pulse was at 107 to 121, and BP was at 162/102, so patient was given an oatmeal bar and transferred to ED (emergency department). The patient did not receive any treatment medication for the event. Upon evaluation in ED at 10:49, the patient stated symptoms had resolved. The patient was discharged at 12:22.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Heart rate, Heart rate increased, Palpitations, Throat tightness
Clinical narrative: Throat tightness; BP 159/84 / BP 162/102; Lightheadedness; Generalized chills / mild rigors; Warmth to body; Palpitations; Pulse 107-121; This is a spontaneous report received from a contactable pharmacist. A 33-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: E19266), via an unspecified route of administration in left arm on 20Feb2021 at 15:30 (age at the time of vaccination was 33-year-old) as a single dose for COVID-19 immunization. The patient did not receive any other vaccines with 4 weeks prior to the COVID vaccine. The patient's medical history was not reported. The patient's concomitant medication included Motrin 600 mg prior to arrival for headache, start and stop date were not reported. It was unknown whether the patient was diagnosed with COVID-19 prior to the vaccination or test for COVID-19 post vaccination.Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9261), via an unspecified route of administration in left arm on 03Feb2021 (age at the time of vaccination was 33-year-old) as a single dose for COVID-19 immunization. On 22Feb2021 immediately after receiving vaccination, the patient complained of complained of light-headedness, generalized chills, warmth to body, and palpitations at 10:04. The patient did not eat breakfast. The patient had similar reaction after receiving the first dose, which self-resolved after a minute.  At 10:05, BP was at 159/84 and pulse 88 (unspecified units); the patient was given water. At 10:25, the patient had verbalized feeling better and was able to ambulate without dizziness. At 10:33, the patient developed chills, mild rigors, and throat tightness. The patient's blood sugar was at 85, pulse was at 107 to 121, and BP was at 162/102, so patient was given an oatmeal bar and transferred to ED (emergency department). The patient did not receive any treatment medication for the event. Upon evaluation in ED at 10:49, the patient stated symptoms had resolved. The patient was discharged at 12:22.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Night sweats
Clinical narrative: Night sweats.; Extreme sweating during the night to the point of sheets being wet; This is a spontaneous report from a contactable other health care professional, the patient. A 52-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 23Mar2021 at 14:00 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to penicillin (PCN). The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 02Mar2021 at 13:45 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. On 24Mar2021 at 00:00, the patient experienced night sweats, extreme sweating during the night to the point of sheets being wet. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcomes of the event night sweats and extreme (excessive) sweating during the night to the point of sheets being wet was recovered on 24Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Lymphadenopathy, Nausea, Pain in extremity
Clinical narrative: Swollen lymph node; low grade fever; Severe nausea; Felt dizzy and lightheaded; Sore arm; This is a spontaneous report from a contactable health care professional, the patient. A 24-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EPT534), via an unspecified route of administration in left arm on 17Mar2021 at 15:15 (at the age of 24-year-old), as a single dose for COVID-19 immunisation. The patients medical history included GERD, 4 knees surgery (reportedly one was in last month) and spring allergies. The patient was allergic to azithromycin, chlorohexidine and tramadol. Concomitant medications included omeprazole(MANUFACTURER UNKNOWN), ibuprofen(MANUFACTURER UNKNOWN), acetaminophen(MANUFACTURER UNKNOWN) and loratadine (MANUFACTURER UNKNOWN) for unknown indications since unknown dates. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 15:15, the patient experienced severe nausea approximately 5 minutes after receiving the vaccine, while she sat down and immediately felt she might puke, dizzy and lightheaded, which only lasted for around 5-10 minutes. On an unknown date in Mar2021, the patient experienced typical sore arm for 3 days and on 20Mar2021, reportedly on the third day  the patient experienced swollen lymph node in her armpit and low-grade fever (99.5)  The patient did not receive any treatment for the adverse events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea and dizziness lasted for around 5-10 minutes, recovered on 17Mar2021. The clinical outcome of the event sore arm was lasted for 3 days and recovered on an unknown date in Mar2021. The clinical outcome of the events swollen lymph nodes and fever were recovered on unknown date in Mar2021.   No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Swollen lymph node; low grade fever; Severe nausea; Felt dizzy and lightheaded; Sore arm; This is a spontaneous report from a contactable health care professional, the patient. A 24-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EPT534), via an unspecified route of administration in left arm on 17Mar2021 at 15:15 (at the age of 24-year-old), as a single dose for COVID-19 immunisation. The patients medical history included GERD, 4 knees surgery (reportedly one was in last month) and spring allergies. The patient was allergic to azithromycin, chlorohexidine and tramadol. Concomitant medications included omeprazole(MANUFACTURER UNKNOWN), ibuprofen(MANUFACTURER UNKNOWN), acetaminophen(MANUFACTURER UNKNOWN) and loratadine (MANUFACTURER UNKNOWN) for unknown indications since unknown dates. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 15:15, the patient experienced severe nausea approximately 5 minutes after receiving the vaccine, while she sat down and immediately felt she might puke, dizzy and lightheaded, which only lasted for around 5-10 minutes. On an unknown date in Mar2021, the patient experienced typical sore arm for 3 days and on 20Mar2021, reportedly on the third day  the patient experienced swollen lymph node in her armpit and low-grade fever (99.5)  The patient did not receive any treatment for the adverse events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea and dizziness lasted for around 5-10 minutes, recovered on 17Mar2021. The clinical outcome of the event sore arm was lasted for 3 days and recovered on an unknown date in Mar2021. The clinical outcome of the events swollen lymph nodes and fever were recovered on unknown date in Mar2021.   No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cold sweat, Feeling abnormal, Headache, Mobility decreased
Clinical narrative: Can not lift or move arm.; Bad headache; shakes; nausea; clammy feeling; achy joints; Feel awful.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205); via an unspecified route of administration in the right arm (reported as right deltoid) on 23Mar2021 at 08:45 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma and elevated BP. The patient had known allergy to aspirin, monocyclin and a sulfate drug. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown); via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Since the vaccination, the patient was not tested for COVID-19. On 23Mar2021 at 16:00, the patient could not move or lift her arm, experienced bad headache, shakes, nausea, clammy feeling and achy joints. The patient also felt awful. The patient did not receive any treatment for the adverse events. The clinical outcome of bad headache, shakes, nausea, clammy feeling and achy joints, felt awful and could not move or lift arm was not resolved. No follow-up attempts are needed. No further information expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Tremor
Clinical narrative: Can not lift or move arm.; Bad headache; shakes; nausea; clammy feeling; achy joints; Feel awful.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205); via an unspecified route of administration in the right arm (reported as right deltoid) on 23Mar2021 at 08:45 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma and elevated BP. The patient had known allergy to aspirin, monocyclin and a sulfate drug. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown); via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Since the vaccination, the patient was not tested for COVID-19. On 23Mar2021 at 16:00, the patient could not move or lift her arm, experienced bad headache, shakes, nausea, clammy feeling and achy joints. The patient also felt awful. The patient did not receive any treatment for the adverse events. The clinical outcome of bad headache, shakes, nausea, clammy feeling and achy joints, felt awful and could not move or lift arm was not resolved. No follow-up attempts are needed. No further information expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain / when raising arm; This is a spontaneous report from a contactable consumer. A 64 years old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the right arm on 23Mar2021 at 10:45 (at the age of 64 years old) as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 24Mar2021, patient experienced sore right arm and pain when raising the arm. The patient did not receive any treatment for the event. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event pain in arm was recovering at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizzy spell; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL3302) via an unspecified route of administration in the left arm on 29Jan2021 at 13:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and heart disease. The patient had no known allergies. It was reported that the patient received unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EK9231) via an unspecified route of administration in the right arm on 08Jan2021 at 09:00(at the age of 68-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14March2021 at 08:00, the patient experienced dizzy spell. It was reported that the patient had slight dizziness spells. It was reported that 2 about a week ago and 2 today (24Mar2021). Does not last very long, only a couple moments. The patient reported that never had dizzy spells before. No therapeutic measures were taken for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of dizzy spell was recovered on an unspecified date Mar2021.    No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea
Clinical narrative: Headache; chills; Nausea; This is a spontaneous report received from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in left arm on 22Mar2021 at 18:30 (at the age of 43-years-old) as single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included VITA FUSION GUMMIES and FLO VITAMINS. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Mar2021, the patient experienced headache, chills and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events headache, chills and nausea was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Headache, Myalgia
Clinical narrative: Diarrhea; Nausea; Headache; Sore muscles; Sore joints; Stuff sore arm; Chills; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732), via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medication included vitamin C (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN); all for unknown indication started from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 02Mar2021 at 10:00 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 22:00, the patient experienced stuff sore arm, chills, diarrhea, nausea, headache, sore muscles and joints. Therapeutic measures were taken as a result of adverse events and included treatment with ADVIL and TYLENOL. The clinical outcome of stuff sore arm, chills, diarrhea, nausea, headache, sore muscles and joints was resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: Diarrhea; Nausea; Headache; Sore muscles; Sore joints; Stuff sore arm; Chills; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732), via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medication included vitamin C (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN); all for unknown indication started from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 02Mar2021 at 10:00 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 22:00, the patient experienced stuff sore arm, chills, diarrhea, nausea, headache, sore muscles and joints. Therapeutic measures were taken as a result of adverse events and included treatment with ADVIL and TYLENOL. The clinical outcome of stuff sore arm, chills, diarrhea, nausea, headache, sore muscles and joints was resolving at the time of report.  No follow-up attempts are needed. No further information is expected.